Category: Insights

For years, psychedelics have lived in the realm of conversation; discussed in research circles, explored in startups, and debated in culture. That moment is over. The White House recently announced new actions aimed at accelerating research and expanding access to psychedelic-assisted therapies for serious mental illness. It’s a signal that this category is no longer […]